K Number
K131877
Manufacturer
Date Cleared
2014-03-21

(269 days)

Product Code
Regulation Number
868.5925
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The SA Ve II™ series are intended to provide short-term ventilatory support to adults during CPR or when Positive-Pressure Ventilation (PPV) is required to manage Acute Respiratory Failure (ARF). The SAVe 11™ series are appropriate for adults that weigh at least 45 kg. It is intended to be used in pre-hospital, field hospitals, and transport environments.

Device Description

The SAVe II™ and SAVe II™ Basic ventilators are battery powered compressors to deliver automated, controlled positive pressure breaths with ambient air for up to 10 hours. It is designed to augment the capabilities of first responders by supplementing Bag Valve Mask (BVM) manual ventilation delivery with an automated solution that can be rapidly deployed by minimally skilled providers in environments where compressed oxygen is unavailable or ill-advised.

To support use in emergency situations, the SA Ve II™ is portable and easy to carry. Rapid initial setup is enabled by default ventilator settings based on adult patient's height, ranging from 4'6'' to 6'6" weighing at least 45 kg, organized in a circular-shaped graphic. To mitigate the risk of patient injury, airway pressure is monitored and users are alerted to potentially dangerous low and high pressure situations. Immediate patient injury due to high pressure is avoided by a pressure cut-off that triggers an exhalation if inspiratory pressure exceeds device settings. Rapid troubleshooting is enabled by visual alarm indicators located together at the bottom of the unit that identifies the most likely cause of the triggered alarm.

AI/ML Overview

Here's a breakdown of the acceptance criteria and the study method for the AutoMedx SAVe II™ and SAVe II™ Basic devices, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

The submission primarily focuses on demonstrating substantial equivalence to predicate devices rather than establishing novel performance criteria with specific acceptance thresholds. The "acceptance criteria" are implied by the features and performance characteristics of the predicate devices. The reported device performance aligns with these characteristics.

Feature/CharacteristicSAVe II™ Acceptance Criteria (based on Impact Model 754 K931473)SAVe II™ Reported PerformanceSAVe II™ Basic Acceptance Criteria (based on AutoMedx SAVe™ K071221)SAVe II™ Basic Reported Performance
Indications for UseShort-term ventilatory support for adults during CPR or ARF in pre-hospital, field hospital, and transport settings.IdenticalShort-term ventilatory support for adults during CPR or ARF in pre-hospital, field hospital, and transport settings.Identical
Patient PopulationAdult, Pediatric, Infants (Predicate)Adult Patients weighing >45 kgPatients weighing >45 kg (Predicate)Adult Patients weighing >45 kg
Operating PrincipleBattery-powered ventilator with internal compressor, software-controlledIdenticalBattery-powered ventilator with internal compressor, software-controlledIdentical
Breath TypeVolume-targeted, Time-cycled, Pressure limitedIdenticalVolume-targeted, Time-cycled, Pressure limitedIdentical
Main Ventilation ModeAssist ControlIdenticalAssist ControlIdentical
Air SourceAmbient / OxygenIdenticalAmbient / OxygenIdentical
TV [mL/breath]0 - 3000 (Predicate)200 - 800 (increments of 50)600 (fixed) (Predicate)300 - 700 (increments of 100)
RR [br/min]1 to 150 (Predicate)8 - 2010 (fixed) (Predicate)10 (fixed)
Inspiratory Flow [L/min]Up to 60 (Predicate)Up to 27Up to 17 (Predicate)Up to 27
I:E Ratio1:1 to 1:599 (Predicate)Fixed at 1:3 or 1:2Fixed at 1:2 (Predicate)Fixed at 1:3 or 1:2
PIP Limit [cmH2O]15 - 100 (Predicate)10 - 6038 (Predicate)30 (fixed)
PEEP [cmH2O]0 - 20 (Predicate)Internal: 0 - 100 (Predicate)0 (fixed)
Supplemental Oxygen (FIO2)21 - 100%Identical21 - 60% (Predicate)21 - 100%
AlarmsStartup Self-Test, Circuit Disconnect, Over Pressure / Blockage, External Power Indicator, Low Battery, Detect Spontaneous Breath, Excessive PEEP, I:E Ratio ExceededAll present, plus Device Temperature Too HighStartup Self-Test, Circuit Disconnect, Over Pressure / Blockage, External Power Indicator, Low Battery, Detect Spontaneous Breath, Device Temperature Too High, Excessive PEEPAll present
Weight [lbs]13.0 (Predicate)2.63.1 (Predicate)2.6
Display/User InterfaceRotary Switches, LEDs, Graphic Display (Predicate)Membrane Panel, LEDs, 7-Segment Displays, Increment/Decrement ButtonsRotary Switch, LEDs (Predicate)Membrane Panel, LEDs, 7-Segment Displays
Battery Duration3 hrs (internal pump) / 12 hrs (external gas) (Predicate)10 hrs @TV=600,RR=10,PEEP=55.5 hrs @TV=600,RR=10,PEEP=0 (Predicate)10 hrs @TV=600,RR=10,PEEP=0
External Power SupplyInput: 90 – 265 VAC / 47 – 400 Hz Output: 12 VDC (Predicate)Input: 100 - 240 VAC / 50 - 60 Hz Output: 16.8 VDCInput: 100 - 240 VAC / 47 - 63 Hz Output: 15 VDC (Predicate)Input: 100 - 240 VAC / 50 - 60 Hz Output: 16.8 VDC

2. Sample Size Used for the Test Set and Data Provenance

The document primarily describes bench testing rather than studies involving human subjects or real-world data.

  • Sample Size: Not specified in terms of numerical units like "cases" or "patients." The testing involved "a complete set of performance testing to the device specifications" and "comparative bench testing to the predicate."
  • Data Provenance: Not applicable in the traditional sense of clinical data. The data is generated from non-clinical bench testing performed by the manufacturer, AutoMedx, Inc. The nature of this testing does not involve country of origin in the context of patient data. It is prospective in the sense that the tests were conducted specifically for this submission.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

Not applicable. The ground truth for bench testing is established by the device's technical specifications and the performance of the predicate device. It does not involve expert image interpretation or clinical diagnosis.

4. Adjudication Method for the Test Set

Not applicable. This is not a clinical study involving human readers or interpretation where adjudication would be necessary. Performance is measured against engineering specifications and comparison to the predicate's technical characteristics.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance

No MRMC comparative effectiveness study was done. This medical device (a ventilator) is not an AI-assisted diagnostic or interpretive tool where human reader performance would be a primary metric.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

Yes, the primary evaluation involved standalone bench testing of the device's performance against its specifications and comparison to predicate devices' technical characteristics. This is an "algorithm only" performance (referring to the device's internal software controlling ventilation parameters), without a human in the loop for interpreting the device's output in the way one would for an AI diagnostic tool. Instead, the device itself delivers the therapy.

7. The Type of Ground Truth Used

The "ground truth" for the non-clinical testing was based on:

  • Device specifications: The SAVe II™ and SAVe II™ Basic were tested to ensure they met their own predefined performance requirements.
  • Predicate device characteristics: The performance of the SAVe II™ models was compared against the known characteristics and performance of the predicate devices (Impact Instruments - Uni-Vent Model 754 - K931473 and AutoMedx - SAVe™ - K071221). Substantial equivalence was claimed if the device performed comparably or better (e.g., in terms of battery life or alarms).

8. The Sample Size for the Training Set

Not applicable. This is not a machine learning or AI device that requires a "training set" in the context of data-driven model development. The device's operation is based on pre-programmed logic and control algorithms.

9. How the Ground Truth for the Training Set Was Established

Not applicable, as no training set was used.

{0}------------------------------------------------

MAR 2 1 2014

K. 131 8 77

AutoMedx SAVe II™

510(k) Summary

510(k) Summary
Page 1 of 12
Date Prepared:18-Mar-14
AutoMedx, Inc.1420 Lakeside Parkway, Suite 102Flower Mound, Texas 75028Tel - 972-586-7500Fax - 972-408-4177
Official Contact:James Evans - President
Proprietary or Trade Name:SA Ve IITMSA Ve IITM Basic
Common/Usual Name:Powered emergency ventilator
Classification Name:Powered emergency ventilatorProcode -- BTLCFR - 868.5925Class 2
Predicate Devices:Impact Instruments - Uni-Vent Model 754 - K931473AutoMedx - SA VeTM - K071221

Device Description:

The SAVe II™ and SAVe II™ Basic ventilators are battery powered compressors to deliver automated, controlled positive pressure breaths with ambient air for up to 10 hours. It is designed to augment the capabilities of first responders by supplementing Bag Valve Mask (BVM) manual ventilation delivery with an automated solution that can be rapidly deployed by minimally skilled providers in environments where compressed oxygen is unavailable or ill-advised.

To support use in emergency situations, the SA Ve II™ is portable and easy to carry. Rapid initial setup is enabled by default ventilator settings based on adult patient's height, ranging from 4'6'' to 6'6" weighing at least 45 kg, organized in a circular-shaped graphic. To mitigate the risk of patient injury, airway pressure is monitored and users are alerted to potentially dangerous low and high pressure situations. Immediate patient injury due to high pressure is avoided by a pressure cut-off that triggers an exhalation if inspiratory pressure exceeds device settings. Rapid troubleshooting is enabled by visual alarm indicators located together at the bottom of the unit that identifies the most likely cause of the triggered alarm.

  • . SAVE IITM
    • This is a full feature unit and the predicate is the Impact Uni-Vent Model 754 o (K931473)
    • o Note the some references have been made to Enhanced SAVe, which is the identical to the SAVe II™
  • SAVe II™ Basic .

  • This is similar to the SAVe II™ but has fewer options and features. o
  • The predicate is the legacy product AutoMedx SAVe (K071221) o

{1}------------------------------------------------

510(k) Summary Page 2 of 12 18-Mar-14

Indications for Use:

The SAVe II™ series are intended to provide short-term ventilatory support to adults during CPR or when Positive-Pressure Ventilation (PPV) is required to manage Acute Respiratory Failure (ARF). The SAVe IITM series are appropriate for adults that weigh at least 45 kg. It is intended to be used in pre-hospital, field hospitals, and transport environments.

Contraindications:

ContraindicationSAVe II™SAVe II™ Basic
Should not be used on patients weighing less than 45kilogramsYesYes
Should not be used in situations where Positive PressureVentilation (PPV) is contraindicated.YesYes
Do not use the device for extended periods withoutmonitoring blood gases. As duration of use increases, theneed for close monitoring of CO2 and O2 levels alsoincreases. This is especially true for patients over 6' 9".YesYes
Spontaneously breathing patients may not synchronize withventilator. If spontaneously breathing patient has difficultysynchronizing with the device, consider discontinuing use.YesYes
Do not set PEEP above zero (0) when performing CPR.YesN/A*

*The SA Ve II™ Basic does not have an adjustable PEEP setting, thus is not applicable.

Technological Characteristics:

The principle of operation for both models is that they use a battery-powered compressor to deliver air to a patient for up to 10 hours on a single charge.

The device is software controlled to deliver ventilation to the patient based upon pre-set parameters, which are based upon height of the adult patient and for the SAVe II™ model may be adjusted by the user.

{2}------------------------------------------------

510(k) Summary Page 3 of 12 18-Mar-14

We use a standard ventilator circuit to connect the SAVe II™ to the patient with the patient connection being face mask, supralaryngeal airway (laryngeal tube), endotracheal tube or tracheostomy tube.

Table 1 - Comparison of the 2 - SAVe II™ Models

SAVE II™SAVE II™ Basic
Indications for UseThe SAVE II™ series are intended toprovide short-term ventilatory supportto adults during CPR or when Positive-Pressure Ventilation (PPV) is requiredto manage Acute Respiratory Failure(ARF). The SAVE II™ series areappropriate for adults that weigh atleast 45 kg. It is intended to be used inpre-hospital, field hospitals, andtransport environments.The SAVE II™ series are intended toprovide short-term ventilatory supportto adults during CPR or whenPositive-Pressure Ventilation (PPV) isrequired to manage Acute RespiratoryFailure (ARF). The SAVE II™ seriesare appropriate for adults that weigh atleast 45 kg. It is intended to be used inpre-hospital, field hospitals, andtransport environments.
User PopulationQualified and trained usersQualified and trained users
Patient PopulationAdults Patients weighing >45 kgAdult Patients weighing >45 kg
Environment of Usepre-hospitalfield hospitalstransportpre-hospitalfield hospitalstransport
Breath Types / Ventilation Modes
Breath TypeVolume-targetedTime-cycledPressure limitedVolume-targetedTime-cycledPressure limited
Main Ventilation ModeAssist ControlAssist Control
Basic and Advanced User ModesYesNo
Manual Triggered BreathYesYes
CPR ModeYesNo
Air SourceAmbient / OxygenAmbient / Oxygen
Settings
TV [mL/breath]200 – 800 increments of 50300 – 700 increments of 100
RR [br/min]8 – 2010 fixed
Inspiratory Flow [L/min]Up to 27Up to 27
I:E RatioFixed at 1:3 or 1:2Fixed at 1:3 or 1:2
PIP Limit [cmH2O]10 – 6030 fixed
PEEP [cmH2O]Internal: 0 – 100 fixed
Supplemental Oxygen (FIO2)21 – 100%21 – 100%

{3}------------------------------------------------

510(k) Summary Page 4 of 12 18-Mar-14

SAVe IITMSAVe II™ Basic
Alarms/Indicators
Start-up Self-TestYesYes
Circuit DisconnectYesYes
Over Pressure / BlockageYesYes
External Power IndicatorYesY cs
Low BatteryYesYes
Detect Spontaneous BreathYesYes
Device Temperature Too HighYesYes
Excessive PEEP ("Breath Stacking")YesYes
I:E Ratio ExceededYesNo
Physical Characteristics
Weight [Ibs]2.62.6
Size6.5" x 6.25" x 2.0" (81 in3)6.5" x 6.25" x 2.0" (81 in3)
Display/User InterfaceMembrane Panel, LEDs, and 7-Membrane Panel, LEDs, and 7-
Segment Displays,Segment Displays
Increment/Decrement Buttons
Interfaces With
Patient Breathing CircuitActive Breathing ValveActive Breathing Valve
OxygenLow flow sourcesLow flow sources
O2 flow metersO2 flow meters
O2 concentratorsO2 concentrators
EtCO2 DetectorYes (External)Yes (External)
Power
BatteryRechargeable, Lithium IonRechargeable, Lithium Ion
Duration per charge10 hrs @TV=600,RR=10,PEEP=510 hrs @TV=600,RR=10,PEEP=0
External Power SupplyInput: 100 - 240 VAC / 50 - 60 HzInput: 100 - 240 VAC / 50 - 60 Hz
Output: 16.8 VDCOutput: 16.8 VDC

Substantial Equivalence Discussion - SAVe IITM

Table 2 compares the SAVe II™ vs. the predicate Impact Model 754 (K931473). One will note that the predicate has more features than the proposed SA Ve II™ and thus one could consider it a subset of the predicate.

It should be noted that our legacy SAVe™ ventilator (K071221) has many of the equivalent function and features of the SAVe IJ™. The legacy SAVe™ used the Impact Model 754 (K931473) as its predicate when it was reviewed and found substantially equivalent.

In addition, we have included in Table 2 a reference predicate, the SA Ve™ ventilator (K071221).

{4}------------------------------------------------

utoMedx SAVe II™

510(k) Summary

510(k) Summary

omparison of Proposed SAVe II™ and Predicate Impact Model 754 (K931473) and Reference – SAVe™ (K071222 Table 2 –

FeaturesSAVe IITMImpact Uni-Vent Model 754K931473)AutoMedxSAVe™-K071221
OverviewRobust functionality in small form factor, completely self-contained, meant to be used by minimally trained providers.Robust functionality in large form factor, completely self-contained, meant to be used by trained providers.Robust functionality in small form factor, completely self-contained, meant to be used by minimally trained providers.
Indications for UseThe SAVe IITM series are intended to provide short-term ventilatory support to adults during CPR or when Positive-Pressure Ventilation (PPV) is required to manage Acute Respiratory Failure (ARF). The SAVe IITM series are appropriate for adults that weigh at least 45 kg. It is intended to be used in pre-hospital, field hospitals, and transport environments.Intended to provide ventilatory support to individuals during CPR or when Positive-Pressure Ventilation (PPV) is required to manage Acute Respiratory Failure (ARF).Intended to provide short-term ventilatory support to individuals during CPR or when Positive-Pressure Ventilation (PPV) is required to manage Acute Respiratory Failure (ARF).
Users PopulationQualified and trained usersQualified and trained usersQualified and trained users
Patient PopulationAdult Patients weighing >45 kgAdult, Pediatric, InfantsPatients weighing >45 kg
Target Environmentpre-hospitalfield hospitalstransportpre-hospitalfield hospitalstransportpre-hospitalfield hospitalstransport
Breath Types / Ventilation Modes
Breath TypeVolume-targetedTime-cycledPressure limitedVolume-targetedTime-cycledPressure limitedVolume-targetedTime-cycledPressure limited
Main Ventilation ModeAssist ControlAssist ControlAssist Control
Basic and Advanced User ModesYesYesNo
Manual Triggered BreathYesYesNo
CPR ModeYesYesNo
FeaturesSAVE IITMImpact Uni-Vent Model 754K931473)AutoMedxSAVe™- K071221
Air SourceAmbient / OxygenAmbient / OxygenAmbient / Oxygen
Settings
TV [mL/breath]200 - 800 increments of 500 - 3000600 (fixed)
RR [br/min]8 - 201 to 15010 (fixed)
Inspiratory Flow [L/min]Up to 27Up to 60Up to 17
I:E RatioFixed at 1:3 or 1:21:1 to 1:599Fixed at 1:2
PIP Limit [cmH2O]10 - 6015 - 10038
PEEP [cmH20]Internal: 0 - 100 - 200
Supplemental Oxygen (FIO2)21 - 100%21 - 100%21 - 60%
Alarms/Indicators
Startup Self-TestYesYesYes
Circuit DisconnectYesYesYes
Over Pressure / BlockageYesYesYes
External Power IndicatorYesYesYes
Low BatteryYesYesYes
Detect Spontaneous BreathYesYesYes
Device Temperature Too HighYesNoYes
Excessive PEEP ("Breath Stacking")YesYesYes
I:E Ratio ExceededYesYesNo
Technological and Physical Characteristics
Source for ventilationInternal, battery operated compressorInternal, battery operated compressorInternal, battery operated compressor
Weight [lbs]2.613.03.1
Display/User InterfaceMembrane Panel, LEDs, and 7-Segment Displays, Increment/Decrement ButtonsRotary Switches, LEDs, Graphic DisplayRotary Switch, LEDs
Interfaces With
Patient Breathing CircuitActive Breathing ValveActive Breathing ValvePassive Breathing Valve
OxygenLow flow sources, O2 flow meters, and O2 concentratorsLow & High flow sources, O2 flow meters, and O2 concentratorsLow flow source, O2 flow meter, and O2 concentrator (up to 10 L/min)
EtCO2 DetectorYes (External)Yes (External)Yes (External)
FeaturesSAVE IITMImpact Uni-Vent Model 754(K931473)AutoMedxSAVETM-K071221
Power
BatteryRechargeable, Lithium IonRechargeable, SLARechargeable, SLA
Duration per charge10 hrs @TV=600,RR=10,PEEP=53 hrs using internal pump12 hours using external gas5.5 hrs @TV=600,RR=10,PEEP=0
External Power SupplyInput: 100 – 240 VAC / 50 – 60 HzOutput: 16.8 VDCInput: 90 – 265 VAC / 47 – 400 HzOutput: 12 VDCInput: 100 – 240 VAC / 47 – 63 HzOutput: 15 VDC

{5}------------------------------------------------

AutoMedx SAVe II™

510(k) Summary

510(k) Summary

:

{6}------------------------------------------------

itoMedx SAVe III

510(k) Summa

0(k) Summar

Page 7 of 12
18-Mar-14

cussion of Substantial Equivalence and Any Differen

he SA Ve II™ is viewed as substantially equivalent to the predicate, Impact Model 754 (K931473) device

ndrations .
Previous in neo which website in the many and Model TS . C. C. (1) . P. P. v. ven Positive Presser Veniliately P.
P. P. resultat manage Acure (A.V.) is incolned i

avironment of Use as aranspor ventilator that on be used in field hopinal, pre-hopid and transport setings which
lenical to the predicate Impact Model 754 (K93) and the subs

{7}------------------------------------------------

510(k) Summary Page 8 of 12 18-Mar-14

Patient Population -

The SAVe IITM is intended for adult patients greater than 45 kg.

Discussion - The predicate Impact Model 754 (K931473) is used for pediatrics to adult and the reference predicate AutoMedx SAVe™ (K071221) for patients greater than 45 kg, the proposed SAVe II™ is within the patient population of the predicates and thus can be considered substantially equivalent.

Technology -

Principle of Operation -

The Save II™ is a battery powered ventilator with an internal compressor which generates the positive pressure to be delivered. It primary gas source is ambient air but supplemental oxygen may be used. It is has integrated software and electronics which control the functions and alarms. The user interface is a membrane panel with LEDs. The patient interface is a standard ventilator circuit that can connect to the patient via a face mask, supraglottic airway, endotracheal tube, or tracheostomy tube.

Discussion - The SAVe II™ and the predicate Impact Model 754 (K931473) as well as the reference predicate AutoMedx SAVe™ (K071221) have the identical operating and technological characteristics and modes of operation. The User Interface of the SAVe II™ is a membrane panel vs. rotary switches for the predicate, which is easier to use and does not pose any new safety concerns.

Alarms -

The SAVe II™ has full complement of alarms expected for a ventilator. These include – circuit disconnect, over pressure / blockage, external power indicator, low battery, detect spontaneous breathing Excessive PEEP, I:E Ratio limits, device temperature too high.

Discussion - The SAVe II™ and the predicate have the same set of alarms, except the SAVe II™ has a device high temperature alarm which for the proposed environment of use is a safety feature.

Materials -

The materials in the gas pathway are identical to the reference predicates, AutoMedx SAVe™ and Impact Model 754, and / or have been tested per VOC and PM3 s.

G95-1 and ISO 10993 would suggest the level of patient contact as:

  • External Communicating (indirect gas pathway) .
  • Tissue contact ●
  • . Limited duration (< 24 hours)

{8}------------------------------------------------

510(k) Summary Page 9 of 12 18-Mar-14

Non-clinical Testing -

Bench Testing -

We have performed a complete set of performance testing to the device specifications and confirmed that the device meets it performance requirements. We also performed comparative bench testing to the predicate.

In addition, we performed durability testing up to 2,000 hours, EMC, EMI, electrical safety, mechanical and environmental testing and Atmospheric Pressure Testing at both 10.15 psia (700 hPa) and 15.95 psia (1100 hPa). The latter represents a simulated altitude of 10,000 feet.

Discussion - We performed a full complement of bench tests that demonstrated that the SAVe II™ met its performance requirements and specifications. It can be considered substantially equivalent to the predicates having undergone similar or identical testing as the predicates.

Substantial Equivalence Conclusion -

The sponsor has demonstrated through performance testing, comparison of design and features, and nonclinical testing that the proposed device and predicate can be found to be substantially equivalent.

Substantial Equivalence Discussion - SAVe II™ - Basic

Table 3 compares the SAVe II™ Basic vs. the predicate AutoMedx SAVe™ (K071221).

Much of the testing that is presented in this submission has been performed on the SAVe [[™ which has more functions and features than the SA Ve II™ Basic: but the entire unit is identical. The only differences, as outlined in Table 1 above, are that some features / functions are removed in the Basic model, making it closer in function to our predicate SAVeTM (K071211).

Discussion of Substantial Equivalence and Any Differences

The SAVe II™ Basic is viewed as substantially equivalent to the predicate AutoMedx SAVe™ (K071221) device because:

Indications -

The proposed indications for use which are to provide short-term ventilatory support to adults during CPR or when Positive-Pressure Ventilation (PPV) is required to manage Acute Respiratory Failure (ARF) is identical to the predicate AutoMedx SAVe™ (K071221).

Discussion - The SAVe II™ Basic is identical to the predicate AutoMedx SAVe™ (K071221).

Environment of Use -

The proposed environments of use as a transport ventilator that can be used in field hospitals as well as pre-hospital and transport settings is identical to the predicate AutoMedx SA Ve™ (K071221).

{9}------------------------------------------------

510(k) Summary Page 10 of 12 18-Mar-14

Discussion - The environments for use are identical to the predicate AutoMedx SAVe™ (K071221) thus the SAVe II™ basic can be found to be substantially equivalent.

Patient Population -

The SAVe II™ Basic is intended for adult patients greater than 45 kg. Discussion - The predicate AutoMedx SA Ve™ (K071221) was cleared for patients greater than 45 kg, the proposed SA Ve II™ Basic fits within the predicate Impact Model 754 (K931473) and thus can be considered substantially equivalent.

Table 3 - Comparison of Proposed SAVe IITM Basic and Predicate AutoMedx SAVe™ K071221)
--------------------------------------------------------------------------------------------
FeaturesSAVe II™ BasicAutoMedxSAVe™ - K071221
Indications for UseThe SAVe II™ series are intended toIntended to provide short-term
provide short-term ventilatory support toventilatory support to individuals
adults during CPR or when Positive-during CPR or when Positive-Pressure
Pressure Ventilation (PPV) is required toVentilation (PPV) is required to
manage Acute Respiratory Failuremanage Acute Respiratory Failure
(ARF). The SAVe IITM series are(ARF).
appropriate for adults that weigh at least
45 kg. It is intended to be used in pre-
hospital. field hospitals, and transport
environments.
Users PopulationQualified and trained usersQualified and trained users
Patient PopulationAdult patients weighing >45 kgPatients weighing >45 kg
Target Environmentpre-hospitalpre-hospital
field hospitalsfield hospitals
hospital transporttransport
Breath TypeVolume-targetedVolume-targeted
Time-cycledTime-cycled
Pressure limitedPressure limited
Main Ventilation ModeAssist ControlAssist Control
Basic and Advanced User ModesNoNo
Manual Triggered BreathNoNo
CPR ModeNoNo
Air SourceAmbient / OxygenAmbient / Oxygen
TV mL/breath300 - 700 increments of 100600 (fixed)
RR br/min10 fixed10 (fixed)
Inspiratory Flow L/min]Up to 27Up to 17
I:E RatioFixed at 1:3 or 1:2Fixed at 1:2
PIP Limit [cmH2O]30 fixed38
PEEP cmH2O0 fixed0
Supplemental Oxygen (FIO2)21 - 100%21 - 60%
Startup Self-TestYesYes
Circuit DisconnectYesYes
Over Pressure / BlockageYesYes
External Power IndicatorYesYes
Low BatteryYesYes
Detect Spontaneous BreathYesYes

{10}------------------------------------------------

510(k) Summary Page 11 of 12 18-Mar-14

FeaturesSAVe II™ BasicAutoMedxSAVe™ - K071221
Device Temperature Too HighYesYes
Excessive PEEP ("Breath Stacking")YesYes
I:E Ratio ExceededNoNo
Source for ventilationInternal, battery operated compressorInternal, battery operated compressor
Weight [Ibs]2.63.1
Display/User InterfaceMembrane Panel, LEDs, and 7-Segment DisplaysRotary Switch, LEDs
Patient Breathing CircuitActive Breathing ValvePassive Breathing Valve
OxygenLow flow sources, O2 flow meters, andO2 concentratorsLow flow source, O2 flow meter, andO2 concentrator (up to 10 L/min)
EtCO2 DetectorYes (External)Yes (External)
BatteryRechargeable, Lithium IonRechargeable, Lithium Ion
Duration per charge10 hrs @TV=600,RR=10,PEEP=05.5 hrs @TV=600,RR=10,PEEP=0
External Power SupplyInput: 100 - 240 VAC / 50 - 60 HzOutput: 16.8 VDCInput: 100 - 240 VAC / 47 - 63 HzOutput: 15 VDC

Technology -

Principle of Operation -

The Save II™ Basic is a battery powered ventilator with an internal compressor which generates the positive pressure to be delivered. It primary gas source is ambient air but supplemental oxygen may be used. It is has integrated software and electronics which control the functions and alarms. The user interface is a membrane panel with LEDs. The patient interface is a standard ventilator circuit that can connect to the patient via a face mask, supraglottic airway, endotracheal tube, or tracheostomy tube. Discussion - The SAVe II™ Basic and the predicate AutoMedx SAVe™ (K071221) have the identical operating and technological characteristics and modes of operation. The User Interface of the SA Ve II™ Basic is a membrane panel which is identical to the predicate.

Alarms -

The SAVe II™ Basic has full complement of alarms expected for a ventilator. These include - circuit disconnect, over pressure / blockage, external power indicator, low battery, detect spontaneous breathing Excessive PEEP, and device temperature too high.

Discussion - The SAVe II™ Basic and the predicate have the same set of alarms.

Non-clinical Testing -

Bench Testing -

We have performed a complete set of performance testing to the device specifications and confirmed that the device meets it performance requirements.

{11}------------------------------------------------

510(k) Summary Page 12 of 12 18-Mar-14

In addition, we performed durability testing up to 2,000 hours, EMC, EMI, electrical safety, mechanical and environmental testing and Atmospheric Pressure Testing at both 10.15 psia (700 hPa) and 15.95 psia (1100 hPa). The latter represents a simulated altitude of 10,000 feet.

Discussion - We performed a full complement of bench tests that demonstrated that the SA Ve IITM which would include the SA Ve II™ Basic, met its performance requirements and specifications. It can be considered substantially equivalent to the predicates having undergone similar or identical testing as the predicates.

Substantial Equivalence Conclusion -

The sponsor has demonstrated through performance testing, comparison of design and features, and nonclinical testing that the proposed device and predicate can be found to substantially equivalent.

{12}------------------------------------------------

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

March 21, 2014

AutoMedx, Incorporated C/O Mr. Paul Dryden Regulatory Consultant 1420 Lakeside Parkway, Suite 102 Flower Mound, Texas 75028

Re: K131877 Trade/Device Name: SAVe IITM SAVe II™ Basic Regulation Number: 21 CFR 868.5925 Regulation Name: Ventilator, Emergency, Powered (Resuscitator) Regulatory Class: II Product Code: BTL Dated: February 14, 2014 Received: February 18, 2014

Dear Mr. Dryden:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Image /page/12/Picture/9 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of an eagle.

{13}------------------------------------------------

Page 2 - Mr. Dryden

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Tejashri Purohit-Sheth, M.D.
Clinical Deputy Director
DAGRID

FOR

Erin I. Keith, M.S. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{14}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: December 31, 2013 See PRA Statement on last page.

510(k) Number (if known) K131877

Device Name SA Ve II™ and SA Ve II™ Basic

Indications for Use (Describe)

The SA Ve II™ series are intended to provide short-term ventilatory support to adults during CPR or when Positive-Pressure Ventilation (PPV) is required to manage Acute Respiratory Failure (ARF). The SAVe 11™ series are appropriate for adults that weigh at least 45 kg. It is intended to be used in pre-hospital, field hospitals, and transport environments.

Type of Use (Select one or both, as applicable)

🇿 Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
Anya C. Harry -
S
2014.03.20
14:22:18 -04'00'
FORM FDA 3881 (9/13)Page 1 of 2
PSC Publishing Services (301) 443-6740 EF

{15}------------------------------------------------

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

§ 868.5925 Powered emergency ventilator.

(a)
Identification. A powered emergency ventilator is a demand valve or inhalator intended to provide emergency respiratory support by means of a face mask or a tube inserted into a patient's airway.(b)
Classification. Class II (performance standards).